Market Cap 286.70M
Revenue (ttm) 92.13M
Net Income (ttm) -18.66M
EPS (ttm) N/A
PE Ratio 38.47
Forward PE 42.14
Profit Margin -20.25%
Debt to Equity Ratio 0.23
Volume 80,100
Avg Vol 311,120
Day's Range N/A - N/A
Shares Out 18.64M
Stochastic %K 84%
Beta 1.24
Analysts Strong Sell
Price Target $24.33

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awa...

Industry: Health Information Services
Sector: Healthcare
Phone: 248 651 6568
Address:
260 Charles Street, Suite 302, Waltham, United States
Iightning
Iightning Nov. 26 at 5:15 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $18 Call | Enter: $0.28 Exit: $0.54 | Profit: 97.11% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 3:23 PM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $18 Call | Enter: $0.28 Exit: $0.54 | Profit: 97.11% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:17 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $18 Call | Enter: $0.28 Exit: $0.54 | Profit: 97.11% ROI | https://1ightning.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:43 PM
0 · Reply
Iightning
Iightning Nov. 22 at 1:29 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 4:51 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 2:33 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:26 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
HappyStockholder
HappyStockholder Nov. 18 at 7:32 PM
$OPRX I know the market has gone sour, but OPRX started going down before that, and seems to be picking up speed. Buying opportunity or falling knife?
0 · Reply
JarvisFlow
JarvisFlow Nov. 17 at 12:55 PM
Stephens & Co. has adjusted their stance on OptimizeRx ( $OPRX ), setting the rating to Equal-Weight with a target price of 20 → 17.
0 · Reply
Latest News on OPRX
4 Top AI-Powered Healthcare Stocks

Oct 9, 2025, 5:00 AM EDT - 7 weeks ago

4 Top AI-Powered Healthcare Stocks

BSX VEEV ZEPP


OptimizeRx: How The Stock Is Changing Pharma Marketing

Oct 7, 2025, 10:02 PM EDT - 7 weeks ago

OptimizeRx: How The Stock Is Changing Pharma Marketing


OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:26 PM EDT - 4 months ago

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript


OptimizeRx: Stock Could Rise As Profitability Is Achieved

Jul 18, 2025, 3:47 PM EDT - 4 months ago

OptimizeRx: Stock Could Rise As Profitability Is Achieved


OptimizeRx to Participate in Upcoming Investor Conferences

May 16, 2025, 7:30 AM EDT - 7 months ago

OptimizeRx to Participate in Upcoming Investor Conferences


OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:56 PM EDT - 7 months ago

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 11:04 AM EDT - 9 months ago

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:58 PM EST - 1 year ago

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

May 14, 2024, 11:21 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript


OptimizeRx Reports First Quarter 2024 Financial Results

May 14, 2024, 4:01 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2024 Financial Results


OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 11:20 AM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 11:48 AM EST - 2 years ago

OptimizeRx Corporation (OPRX) Q3 2023 Earnings Call Transcript


Iightning
Iightning Nov. 26 at 5:15 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $18 Call | Enter: $0.28 Exit: $0.54 | Profit: 97.11% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 3:23 PM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $18 Call | Enter: $0.28 Exit: $0.54 | Profit: 97.11% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:17 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $18 Call | Enter: $0.28 Exit: $0.54 | Profit: 97.11% ROI | https://1ightning.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:43 PM
0 · Reply
Iightning
Iightning Nov. 22 at 1:29 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 4:51 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 2:33 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:26 AM
1ightning® Options Trade Alert (Actionable) | Buy $OPRX Dec 19 $15 Call | Enter: $1.45 Exit: $2.56 | Profit: 76.48% ROI | https://1ightning.com
0 · Reply
HappyStockholder
HappyStockholder Nov. 18 at 7:32 PM
$OPRX I know the market has gone sour, but OPRX started going down before that, and seems to be picking up speed. Buying opportunity or falling knife?
0 · Reply
JarvisFlow
JarvisFlow Nov. 17 at 12:55 PM
Stephens & Co. has adjusted their stance on OptimizeRx ( $OPRX ), setting the rating to Equal-Weight with a target price of 20 → 17.
0 · Reply
HappyStockholder
HappyStockholder Nov. 12 at 12:53 PM
$OPRX Strange price action since stellar earnings results, raised outlook, and several analyst price target increases. I have taken this opportunity to open an investment here.
0 · Reply
sofocles
sofocles Nov. 7 at 3:02 PM
$OPRX GREAT QUARTER RESULTS. JUST A MATTER OF TIME FOR RECOVERY
0 · Reply
DARKP00L
DARKP00L Nov. 7 at 2:24 PM
$OPRX 09:07 on Nov. 07 2025 Citizens Maintains Market Outperform on OptimizeRx, Raises Price Target to $24 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:59 PM
Citizens has updated their rating for OptimizeRx ( $OPRX ) to Market Outperform with a price target of 24.
0 · Reply
Doozio
Doozio Oct. 26 at 9:23 PM
$OPRX MLYS gonna become BILI’s before 🐒🍌🧠⏰♾️ ends?
0 · Reply
sofocles
sofocles Oct. 24 at 5:35 PM
$OPRX any news here?
0 · Reply
MaverikIT
MaverikIT Oct. 14 at 8:51 PM
$OPRX - trying to break out
0 · Reply
WrappedLunatic
WrappedLunatic Oct. 7 at 12:41 AM
$OPRX yikes
0 · Reply
LayerOne
LayerOne Oct. 5 at 3:52 PM
$OPRX Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.
0 · Reply
sirspanky
sirspanky Oct. 3 at 7:30 PM
$HCTI 🚀 Bullish quick hits • Platform traction: QuantumNexis on Ezovion has processed $20M$37M projected usage; gateway adds a take-rate lever (recurring fees). • Valuation gap: Trading near micro-cap lows while our base-case math pencils $5$6.5/sh on conservative EV/Sales vs peers. • Runway improved: Recent cash in from warrant exercises extends operations and funds growth. • Multi-region scale: India/KSA/Malaysia expansion + marketplace routes make onboarding easier. • Catalysts ahead: Gateway go-live, new logos, regulatory/commercial updates. Bottom line: execution + multiple expansion is the setup. Watching $3 reclaim next. Peers to watch: $OPRX $HIMS #DigitalHealth #AIinHealthcare
0 · Reply
sirspanky
sirspanky Oct. 2 at 3:06 PM
$HCTI Cliffs after the dip • Why it fell: Warrant inducement = quick cash now (~$1.63M) but near-term dilution. New share count ≈ 6.75M. • Where we stand: At $2.54, implied EV ≈ $9.2M vs $12–14M revenue → only 0.6–0.8× EV/Sales (micro-cap peers often 2.0–3.5×). • Fair value math: Base case ~$6.47/sh (post-deal). Even if all new $3 warrants exercise later, FV still ~$6.10/sh (fully diluted). • Execution tailwinds: QuantumNexis/Ezovion $20M processed → $37M guide; payment gateway adds a take-rate monetization lever. • Watch next: 8-K terms, gateway go-live, regional wins (India/KSA/MY), new logos. Bottom line: The deal stung, but cash runway improved and valuation is well below conservative comps. If execution continues, multiple expansion is the story. $HCTI $OPRX $HIMS (Not financial advice.)
0 · Reply
sirspanky
sirspanky Oct. 2 at 2:10 PM
$HCTI 🚀 QuantumNexis Milestone on Ezovion EMR: $20M processed in usage-based revenue, guiding to $37M in coming months + integrated payment gateway on deck. This is real platform throughput + a clear path to monetize volume (take-rate) across India, Bangladesh, KSA, Malaysia. Why it matters: • Proof of adoption → recurring, higher-margin potential • Fintech rails = new revenue lever (fees) • Expansion across multiple regions = durability, not one-off If execution continues, multiple expansion becomes the story. Watching for gateway rollout, new logos, and marketplace wins. Peers to watch: $RCM $OPRX $HIMS
0 · Reply